Evidence map›Paper›PMID 26977121›Full record

Trial reportMediators of inflammation2016

Effects of Standardised Fermented Papaya Gel on Clinical Symptoms, Inflammatory Cytokines, and Nitric Oxide Metabolites in Patients with Chronic Periodontitis: An Open Randomised Clinical Study.

Zaira F Kharaeva, Lyana R Zhanimova, Magomet Sh Mustafaev, Chiara De Luca, Wolfgang Mayer, Jeffrey Chung Sheun Thai, Rebecca Tiew Siok Tuan, Liudmila G Korkina

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Mediators of inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. FermentedNutrients · 2022
    Trial
  5. Review
  6. Review
  7. Article
  8. Beneficial Role ofBiology · 2021
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Zaira F KharaevaKabardino-Balkar Berbekov's State University, 176 Chernishevskogo Street, Nal'chik 360000, Russia.
Lyana R ZhanimovaKabardino-Balkar Berbekov's State University, 176 Chernishevskogo Street, Nal'chik 360000, Russia.
Magomet Sh MustafaevKabardino-Balkar Berbekov's State University, 176 Chernishevskogo Street, Nal'chik 360000, Russia.
Chiara De LucaMedena AG, 16 Industriestrasse, 8910 Affoltern am Albis, Switzerland.
Wolfgang MayerMedena AG, 16 Industriestrasse, 8910 Affoltern am Albis, Switzerland.
Jeffrey Chung Sheun ThaiNatural Health Farm, 39 Jalan Pengacara U1/48, Temasya Industrial Park, 40150 Shah Alam, Selangor, Malaysia.
Rebecca Tiew Siok TuanNatural Health Farm, 39 Jalan Pengacara U1/48, Temasya Industrial Park, 40150 Shah Alam, Selangor, Malaysia.
Liudmila G KorkinaCentre of Innovative Biotechnological Investigations "Nanolab", 197 Vernadskiy Prospekt, Moscow 119571, Russia.
Kabardino-Balkarian State University · RUUniversiti Teknologi MARA System · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical efficacy of topical administration of standardised fermented papaya gel (SFPG), known to have antioxidant and anti-inflammatory properties, versus conventional therapy was evaluated in a group of 84 patients with moderate-to-severe periodontitis, randomly assigned to control group (n = 45) undergoing traditional pharmacologic/surgical protocols or to experimental group (n = 39), additionally treated with intragingival pocket SFPG (7 g) applications (15 min daily for 10 days). Patients undergoing SFPG treatment showed significant (P < 0.05), durable improvement of three major clinical indices of disease severity: reduced bleeding (day 7), plaque and gingival conditions (day 14), and consistent gingival pocket depth reduction (day 45). Proinflammatory nitric oxide metabolites reached normal values in plasma (day 14) and gingival crevicular fluid (GCF) at day 45 with SFPG applications compared to controls that did not reach normalisation. Levels of highly increased proinflammatory (IL-1B, IL-6) and suppressed anti-inflammatory (IL-10) cytokines normalised in the SFPG group by days 14 (plasma) and 45 (GCF), but never in the control group. Although not acting directly as antibiotic, SFPG acted in synergy with human granulocytes blocking adaptive catalase induction in S. aureus in response to granulocyte-derived oxidative stress, thus enhancing intracellular bacterial killing.

Indexed as

AdultAnti-Inflammatory AgentsAntioxidantsCaricaChronic PeriodontitisCytokinesFemaleGingivaHumansMaleMiddle AgedNitric OxideAnti-Inflammatory AgentsAntioxidantsCytokinesNitric Oxide

Identifiers

PMID26977121
PMCPMC4764753
OpenAlexW2253947635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.